Vascular and cognitive effects of cocoa-rich chocolate in postmenopausal women: a study protocol for a randomised clinical trial

Irene A Garcia-Yu, Luis Garcia-Ortiz, Manuel A Gómez-Marcos, Rosario Alonso-Dominguez, Jesus Gonzalez-Sanchez, Sara Mora-Simon, Susana González-Manzano, Emiliano Rodriguez-Sanchez, Jose A Maderuelo-Fernandez, Jose I Recio-Rodriguez, Irene A Garcia-Yu, Luis Garcia-Ortiz, Manuel A Gómez-Marcos, Rosario Alonso-Dominguez, Jesus Gonzalez-Sanchez, Sara Mora-Simon, Susana González-Manzano, Emiliano Rodriguez-Sanchez, Jose A Maderuelo-Fernandez, Jose I Recio-Rodriguez

Abstract

Introduction: The intake of polyphenols has certain health benefits. This study will aim to assess the effect of adding a daily amount of chocolate high in cocoa content and polyphenols to the normal diet on blood pressure, vascular function, cognitive performance, quality of life and body composition in postmenopausal women.

Methods and analysis: Here we plan a randomised clinical trial with two parallel groups involving a total of 140 women between 50 and 64 years in the postmenopausal period, defined by amenorrhoea of ​​at least 12 consecutive months. The main variable will be the change in blood pressure. Secondary variables will be changes in vascular function, quality of life, cognitive performance and body composition. The intervention group will be given chocolate containing 99% cocoa, with instructions to add 10 g daily to their normal diet for 6 months. The daily nutritional contribution of this amount of chocolate is 59 kcal and 65.4 mg of polyphenols. There will be no intervention in the control group. All variables will be measured at the baseline visit and 3 and 6 months after randomisation, except cognitive performance and quality of life, which will only be assessed at baseline and at 6 months. Recruitment is scheduled to begin on 1 June 2018, and the study will continue until 31 May 2019.

Ethics and dissemination: This study was approved by the Clinical Research Ethics Committee of the Health Area of Salamanca, Spain ('CREC of Health Area of Salamanca'), in February 2018. A SPIRIT checklist is available for this protocol. The clinical trial has been registered at ClinicalTrials.gov provided by the US National Library of Medicine, number NCT03492983. The results will be disseminated through open access peer-reviewed journals, conference presentations, broadcast media and a presentation to stakeholders.

Keywords: arterial pressure; body composition; chocolate; postmenopause; quality of life; vascular stiffness.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Study flow chart.

References

    1. Grassi D, Desideri G, Ferri C. Flavonoids: antioxidants against atherosclerosis. Nutrients 2010;2:889–902. 10.3390/nu2080889
    1. Grassi D, Desideri G, Croce G, et al. . Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 2009;15:1072–84. 10.2174/138161209787846982
    1. Visioli F, Bernaert H, Corti R, et al. . Chocolate, lifestyle, and health. Crit Rev Food Sci Nutr 2009;49:299–312. 10.1080/10408390802066805
    1. Cos P, De Bruyne T, Hermans N, et al. . Proanthocyanidins in health care: current and new trends. Curr Med Chem 2004;11:1345–59. 10.2174/0929867043365288
    1. Grassi D, Desideri G, Ferri C. Blood pressure and cardiovascular risk: what about cocoa and chocolate? Arch Biochem Biophys 2010;501:112–5. 10.1016/j.abb.2010.05.020
    1. Mink PJ, Scrafford CG, Barraj LM, et al. . Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85:895–909. 10.1093/ajcn/85.3.895
    1. Ramos S, Martín MA, Goya L. Effects of cocoa antioxidants in type 2 diabetes mellitus. Antioxidants 2017;6:84 10.3390/antiox6040084
    1. Osakabe N. Flavan 3-ols improve metabolic syndrome risk factors: evidence and mechanisms. J Clin Biochem Nutr 2013;52:186–92. 10.3164/jcbn.12-130
    1. Engler MB, Engler MM, Chen CY, et al. . Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 2004;23:197–204. 10.1080/07315724.2004.10719361
    1. Ottaviani JI, Heiss C, Spencer JPE, et al. . Recommending flavanols and procyanidins for cardiovascular health: Revisited. Mol Aspects Med 2018;61:63–75. 10.1016/j.mam.2018.02.001
    1. Ludovici V, Barthelmes J, Nägele MP, et al. . Cocoa, blood pressure, and vascular function. Front Nutr 2017;4:36 10.3389/fnut.2017.00036
    1. Ried K, Fakler P, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst Rev 2017;4:CD008893 10.1002/14651858.CD008893.pub3
    1. Heiss C, Sansone R, Karimi H, et al. . FLAVIOLA Consortium, European Union 7th Framework Program. Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial. Age 2015;37:9794 10.1007/s11357-015-9794-9
    1. Grassi D, Desideri G, Necozione S, et al. . Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals. J Hypertens 2015;33:294–303. 10.1097/HJH.0000000000000412
    1. Crews WD, Harrison DW, Wright JW. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 2008;87:872–80. 10.1093/ajcn/87.4.872
    1. Dower JI, Geleijnse JM, Gijsbers L, et al. . Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am J Clin Nutr 2015;101:914–21. 10.3945/ajcn.114.098590
    1. Modena MG. Hypertension in postmenopausal women: how to approach hypertension in menopause. High Blood Press Cardiovasc Prev 2014;21:201–4. 10.1007/s40292-014-0057-0
    1. Zilberman JM, Cerezo GH, Del Sueldo M, et al. . Association between hypertension, menopause, and cognition in women. J Clin Hypertens 2015;17:970–6. 10.1111/jch.12643
    1. Okamoto T, Kobayashi R, Natsume M, et al. . Habitual cocoa intake reduces arterial stiffness in postmenopausal women regardless of intake frequency: a randomized parallel-group study. Clin Interv Aging 2016;11:1645–52. 10.2147/CIA.S118152
    1. Koli R, Köhler K, Tonteri E, et al. . Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study. Nutr J 2015;14:84 10.1186/s12937-015-0075-3
    1. West SG, McIntyre MD, Piotrowski MJ, et al. . Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults. Br J Nutr 2014;111:653–61. 10.1017/S0007114513002912
    1. Basu A, Betts NM, Leyva MJ, et al. . Acute Cocoa Supplementation Increases Postprandial HDL Cholesterol and Insulin in Obese Adults with Type 2 Diabetes after Consumption of a High-Fat Breakfast. J Nutr 2015;145:2325–32. 10.3945/jn.115.215772
    1. Scholey AB, French SJ, Morris PJ, et al. . Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol 2010;24:1505–14. 10.1177/0269881109106923
    1. Field DT, Williams CM, Butler LT. Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiol Behav 2011;103:255–60. 10.1016/j.physbeh.2011.02.013
    1. Sorond FA, Hurwitz S, Salat DH, et al. . Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people. Neurology 2013;81:904–9. 10.1212/WNL.0b013e3182a351aa
    1. Socci V, Tempesta D, Desideri G, et al. . Enhancing Human Cognition with Cocoa Flavonoids. Front Nutr 2017;4:19 10.3389/fnut.2017.00019
    1. Mastroiacovo D, Kwik-Uribe C, Grassi D, et al. . Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trial. Am J Clin Nutr 2015;101:538–48. 10.3945/ajcn.114.092189
    1. Grassi D, Socci V, Tempesta D, et al. . Flavanol-rich chocolate acutely improves arterial function and working memory performance counteracting the effects of sleep deprivation in healthy individuals. J Hypertens 2016;34:1298–308. 10.1097/HJH.0000000000000926
    1. Crichton GE, Elias MF, Alkerwi A. Chocolate intake is associated with better cognitive function: The Maine-Syracuse Longitudinal Study. Appetite 2016;100:126–32. 10.1016/j.appet.2016.02.010
    1. Massee LA, Ried K, Pase M, et al. . The acute and sub-chronic effects of cocoa flavanols on mood, cognitive and cardiovascular health in young healthy adults: a randomized, controlled trial. Front Pharmacol 2015;6:93 10.3389/fphar.2015.00093
    1. Nehlig A. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Br J Clin Pharmacol 2013;75:716–27. 10.1111/j.1365-2125.2012.04378.x
    1. Nurk E, Refsum H, Drevon CA, et al. . Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 2009;139:120–7. 10.3945/jn.108.095182
    1. Neshatdoust S, Saunders C, Castle SM, et al. . High-flavonoid intake induces cognitive improvements linked to changes in serum brain-derived neurotrophic factor: Two randomised, controlled trials. Nutr Healthy Aging 2016;4:81–93. 10.3233/NHA-1615
    1. Marsh CE, Carter HH, Guelfi KJ, et al. . Brachial and Cerebrovascular Functions Are Enhanced in Postmenopausal Women after Ingestion of Chocolate with a High Concentration of Cocoa. J Nutr 2017;147:jn250225–92. 10.3945/jn.117.250225
    1. Balboa-Castillo T, López-García E, León-Muñoz LM, et al. . Chocolate and health-related quality of life: a prospective study. PLoS One 2015;10:e0123161 10.1371/journal.pone.0123161
    1. Costa de Miranda R, Paiva ES, Suter Correia Cadena SM, et al. . Polyphenol-rich foods alleviate pain and ameliorate quality of life in fibromyalgic women. Int J Vitam Nutr Res 2016:1–10. 10.1024/0300-9831/a000253
    1. Dmitruk A, Czeczelewski J, Czeczelewska E, et al. . Body composition and fatty tissue distribution in women with various menstrual status. Rocz Panstw Zakl Hig 2018;69:95–101.
    1. Davison K, Coates AM, Buckley JD, et al. . Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes 2008;32:1289–96. 10.1038/ijo.2008.66
    1. Cuenca-García M, Ruiz JR, Ortega FB, et al. . HELENA study group. Association between chocolate consumption and fatness in European adolescents. Nutrition 2014;30:236–9. 10.1016/j.nut.2013.07.011
    1. Ayoobi N, Jafarirad S, Haghighizadeh MH, et al. . Protective effect of dark chocolate on cardiovascular disease factors and body composition in type 2 diabetes: a parallel, randomized, clinical trial. Iran Red Crescent Med J 2017;19:e21644 10.5812/ircmj.21644
    1. Di Renzo L, Rizzo M, Sarlo F, et al. . Effects of dark chocolate in a population of normal weight obese women: a pilot study. Eur Rev Med Pharmacol Sci 2013;17:2257–66.
    1. González-Sarrías A, Combet E, Pinto P, et al. . A systematic review and meta-analysis of the effects of flavanol-containing tea, cocoa and apple products on body composition and blood lipids: exploring the factors responsible for variability in their efficacy. Nutrients 2017;9:746 10.3390/nu9070746
    1. Kord-Varkaneh H, Ghaedi E, Nazary-Vanani A, et al. . Does cocoa/dark chocolate supplementation have favorable effect on body weight, body mass index and waist circumference? A systematic review, meta-analysis and dose-response of randomized clinical trials. Crit Rev Food Sci Nutr 2018;0:1–14. 10.1080/10408398.2018.1451820
    1. Greenberg JA, Buijsse B. Habitual chocolate consumption may increase body weight in a dose-response manner. PLoS One 2013;8:e70271 10.1371/journal.pone.0070271
    1. Agrinier N, Cournot M, Dallongeville J, et al. . Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas 2010;65:237–43. 10.1016/j.maturitas.2009.11.023
    1. Consellería de Sanidade Xunta de Galicia. Spain; Pan American Organization health (PAHO-WHO); CES University C. Epidat: program for epidemiological data analysis. Version 4.2Julio. 2016.
    1. Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2012;102809.
    1. Allen JK, Stephens J, Dennison Himmelfarb CR, et al. . Randomized controlled pilot study testing use of smartphone technology for obesity treatment. J Obes 2013;2013:1–7. 10.1155/2013/151597
    1. Shirai K, Hiruta N, Song M, et al. . Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011;18:924–38. 10.5551/jat.7716
    1. Ohkuma T, Tomiyama H, Ninomiya T, et al. . Proposed Cutoff Value of Brachial-Ankle Pulse Wave Velocity for the Management of Hypertension. Circ J 2017;81:1540–2. 10.1253/circj.CJ-17-0636
    1. Korkmaz L, Erkan H, Korkmaz AA, et al. . Relationship of aortic knob width with cardio-ankle vascular stiffness index and its value in diagnosis of subclinical atherosclerosis in hypertensive patients: a study on diagnostic accuracy. Anadolu Kardiyol Derg 2012;12:102–6. 10.5152/akd.2012.034
    1. Reitan RM. Trail making test. Tucson: Reitan Neuropsychology Laboratory, 1992.
    1. Rey A. L’examen clinique en psychologie. Paris: Presses universitaires de France, 1964.
    1. Wechsler D. WMS-R Wechsler memory scale. San Antonio, Texas: The Psychological Corporation, 1987.
    1. Valencia NJ, Laserna JA, Pérez-García M, et al. . Influencia de la escolaridad y el sexo sobre la ejecución en el FAS, nombrar animales y nombrar frutas. Psicología Conductual 2000;8:283–95.
    1. Goodglass HKE. Evaluación de la Afasia y de Trastornos Relacionados, 1986.
    1. Badia X, Schiaffino A, Alonso J, et al. . Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res 1998;7:311–22. 10.1023/A:1008894502042
    1. Palacios S, Ferrer-Barriendos J, Parrilla JJ, et al. . [Health-related quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale]. Med Clin 2004;122:205–11.
    1. Karelis AD, Chamberland G, Aubertin-Leheudre M, et al. . Validation of a portable bioelectrical impedance analyzer for the assessment of body composition. Appl Physiol Nutr Metab 2013;38:27–32. 10.1139/apnm-2012-0129
    1. Salas-Salvadó J, Rubio MA, Barbany M, et al. . [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria]. Med Clinquiz 1 p following 2007;128:184–96.
    1. Román Viñas B, Ribas Barba L, Ngo J, et al. . [Validity of the international physical activity questionnaire in the Catalan population (Spain)]. Gac Sanit 2013;27:254–7. 10.1016/j.gaceta.2012.05.013
    1. Islam MA, Alam F, Solayman M, et al. . Dietary phytochemicals: natural swords combating inflammation and oxidation-mediated degenerative diseases. Oxid Med Cell Longev 2016;2016:1–25. 10.1155/2016/5137431

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner